| Dr Tracey Lynn Asmus, OD | |
|
2691 Berlin Tpke, Newington, CT 06111-4114 | |
| (860) 594-4585 | |
| (860) 667-4377 |
| Full Name | Dr Tracey Lynn Asmus |
|---|---|
| Gender | Female |
| Speciality | Optometry |
| Experience | 28 Years |
| Location | 2691 Berlin Tpke, Newington, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053341701 | NPI | - | NPPES |
| 11241145 | Other | CT | CAQH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 002561 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Starling Physicians, Pllc | 7517863749 | 204 |
News Archive
Today's headlines include previews of a Capitol Hill hearing that will feature Centers for Medicare & Medicaid Serivces Administrator Marilyn Tavenner.
A research team this week will present findings that they say may finally explain the link between alcohol consumption and breast cancer.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 2 days ago
| Provider Name | Starling Physicians, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1467537290 PECOS PAC ID: 7517863749 Enrollment ID: O20031209000877 |
News Archive
Today's headlines include previews of a Capitol Hill hearing that will feature Centers for Medicare & Medicaid Serivces Administrator Marilyn Tavenner.
A research team this week will present findings that they say may finally explain the link between alcohol consumption and breast cancer.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tracey Lynn Asmus, OD 27 Foxtail Rd, Middletown, CT 06457-1770 Ph: (860) 632-8735 | Dr Tracey Lynn Asmus, OD 2691 Berlin Tpke, Newington, CT 06111-4114 Ph: (860) 594-4585 |
News Archive
Today's headlines include previews of a Capitol Hill hearing that will feature Centers for Medicare & Medicaid Serivces Administrator Marilyn Tavenner.
A research team this week will present findings that they say may finally explain the link between alcohol consumption and breast cancer.
Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) released unaudited preliminary financial results for the first quarter of fiscal year 2015.
Orexigen Therapeutics, Inc. today announced data from the CORDiabetes trial for Contrave (naltrexone sustained release (SR)/bupropion SR) showing that after 56 weeks of treatment, overweight or obese patients with type 2 diabetes lost significantly more weight and achieved greater improvement in glycemic control than those treated with placebo.
› Verified 2 days ago
Dr. Mitchel Boyd Strand, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 485 Willard Ave, Newington, CT 06111 Phone: 860-666-7053 Fax: 860-666-7083 | |
Eyeconic Vision Care Llc Optometrist Medicare: Medicare Enrolled Practice Location: 2311 Berlin Tpke, Newington, CT 06111 Phone: 860-667-0921 | |
Janelle C Fern, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 262 Brockett St, Newington, CT 06111 Phone: 860-667-2020 Fax: 860-667-0770 | |
Nguyen Tran, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 262 Brockett St, Newington, CT 06111 Phone: 860-667-2020 Fax: 860-667-0770 | |
Dr. Nora Ann M Lucchi, O.D, Optometrist Medicare: Accepting Medicare Assignments Practice Location: 555 Willard Ave, Newington, CT 06111 Phone: 860-667-6742 | |
Dr. Leonard John Oshinskie, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 555 Willard Ave, Optometry Clinic, Newington, CT 06111 Phone: 860-667-6742 Fax: 860-667-6833 |